2010
Prostaglandin receptors EP2 and IP are detectable in atherosclerotic arteries and plaques.
Muto A, Nishibe T, Miyauchi Y, Kondo Y, Yamamoto Y, Dardik A, Shigematsu H. Prostaglandin receptors EP2 and IP are detectable in atherosclerotic arteries and plaques. International Angiology 2010, 29: 43-8. PMID: 20357748.Peer-Reviewed Original ResearchConceptsArteriosclerosis obliteransAtherosclerotic femoral arteriesPharmacological treatmentFemoral arteryReceptor EP2IP receptorAtherosclerotic plaquesMedial layerAtherosclerotic arteriesWestern blottingSevere arteriosclerosis obliteransFemoropopliteal bypass surgeryCOX-2 expressionProstaglandin receptor agonistsProstaglandin receptor EP2Pharmacological managementBypass surgeryReceptor agonistArterial intimaIntimal layerPG receptorsArteryPlatelet aggregationPatientsEP2
2009
Stent placement in the superficial femoral artery for patients on chronic hemodialysis with peripheral artery disease.
Nishibe T, Kondo Y, Dardik A, Muto A, Koizumi J, Nishibe M. Stent placement in the superficial femoral artery for patients on chronic hemodialysis with peripheral artery disease. International Angiology 2009, 28: 484-9. PMID: 20087287.Peer-Reviewed Original ResearchMeSH KeywordsAgedAngiography, Digital SubtractionAngioplasty, BalloonAnkle Brachial IndexCase-Control StudiesChronic DiseaseFemaleFemoral ArteryHemodynamicsHumansIschemiaKaplan-Meier EstimateKidney DiseasesLimb SalvageMaleMiddle AgedPeripheral Vascular DiseasesRenal DialysisRisk AssessmentRisk FactorsStentsTime FactorsTreatment OutcomeUltrasonography, Doppler, DuplexVascular PatencyConceptsPeripheral artery diseaseSuperficial femoral arteryChronic hemodialysisStent placementNondialysis groupPrimary patencyDialysis groupLimb ischemiaSFA lesionsArtery diseaseLimb salvageFemoral arteryFirst-choice therapeutic optionSymptomatic limb ischemiaCritical limb ischemiaPrimary stent placementClinical outcomesTherapeutic optionsHigh prevalenceOutcome measuresHemodialysisLower limbsPatientsSurvival ratePatencyHybrid surgical and endovascular therapy in multifocal peripheral TASC D lesions: up to three-year follow-up.
Nishibe T, Kondo Y, Dardik A, Muto A, Koizumi J, Nishibe M. Hybrid surgical and endovascular therapy in multifocal peripheral TASC D lesions: up to three-year follow-up. The Journal Of Cardiovascular Surgery 2009, 50: 493-9. PMID: 19734834.Peer-Reviewed Original ResearchMeSH KeywordsAgedAged, 80 and overAngioplasty, BalloonArterial Occlusive DiseasesCombined Modality TherapyConstriction, PathologicEndarterectomyFemaleFemoral ArteryHemodynamicsHumansIliac ArteryIschemiaKaplan-Meier EstimateLimb SalvageLower ExtremityMaleMiddle AgedPeripheral Vascular DiseasesRadiographyReoperationStentsTime FactorsTreatment OutcomeVascular PatencyConceptsCommon femoral artery endarterectomyFemoral artery endarterectomyTASC D lesionsLimb salvage ratePrimary patency rateCritical limb ischemiaPeripheral artery diseaseCommon femoral arteryEndovascular therapySuperficial femoral arteryFemoral arteryPatency ratesArtery endarterectomyIntermittent claudicationArtery diseaseD lesionsLimb ischemiaSalvage rateLower limbsSurvival rateAssisted primary patencyVascular Surgery guidelinesThree-year experienceHemodynamic successPrimary patency
2006
Presence of prostacyclin receptor in arteriosclerotic human femoral artery.
Muto A, Kondo Y, Yamamoto Y, Yamada H, Washimi O, Miyauchi Y, Kudo F, Dardik A, Nishibe T. Presence of prostacyclin receptor in arteriosclerotic human femoral artery. International Angiology 2006, 25: 175-8. PMID: 16763535.Peer-Reviewed Case Reports and Technical NotesConceptsFemoral arteryVascular endothelial cellsEndothelial cellsArteriosclerosis obliteransHuman femoral arteriesProstacyclin analogueIP receptorProstacyclin receptorLuminal sideVon Willebrand factorIschemic symptomsVascular eventsRelaxant effectLower extremitiesCardiovascular homeostasisLimb amputationAtherosclerotic lesionsPositive cellsArterySingle immunohistochemistryWillebrand factorReceptorsStrong expressionObliteransPatients